CLD, such as nonalcoholic steatohepatitis (NASH), is highly associated with the triggering of TLR4 signaling by gut-derived bacteria and cell death products [5,6,7]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.